Maraviroc, the New Drug on the Block
Yesterday’s recommendation to approve Pfizer’s HIV drug Celsentri (maraviroc) followed a day-long hearing before the Food and Drug Administration’s Antiviral Drug Advisory Committee (ADAC) that was anything but a rubber stamp.
April 20, 2007
HIV Stigma and Struggle at Sharpton Conference Yesterday's HIV panel at Al Sharpton’s Ninth Annual National Action Network Convention was not so much a debate on HIV issues in the African American community as an occasion to testify.
Photo Op: Fight HIV Your Way A naked young man pushes against the walls of a stone niche. “I felt boxed in by concepts such as terminal illness, damaged goods, poz/neg," says the photographer.
April 13, 2007
Cylar Awards Celebrate Fearlessness Advocates from around the world donned their party best last night in New York City to celebrate four shining stars of AIDS activism.
Wasting Money: Serostim Users See Payback Two years after the federal government fined Serostim-maker EMD Serono $704 million for marketing the drug to doctors too aggressively, the drug takers and insurance companies that paid for the injectable treatments are about to recoup some of their money.
More Web Exclusives
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
